Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reiko Horikawa

Showing results (141-150 of 212) with videos related to

Pageof 22
Sort By:
Human Genome Variation|September 7, 2025
DHX37 variants in patients with 46,XY disorders or differences of sex developmentYuko Katoh-Fukui, Daisuke Saito, Hiroko Narumi, et al.
The Journal of Clinical Endocrinology and Metabolism|July 5, 2023
Effective GH Replacement With Somapacitan in Children With GHD: REAL4 2-year Results and After Switch From Daily GHBradley S Miller, Joanne C Blair, Michael Højby Rasmussen, et al.
Journal of Human Genetics|June 5, 2015
Rare pseudoautosomal copy-number variations involving SHOX and/or its flanking regions in individuals with and without short statureMaki Fukami, Yasuhiro Naiki, Koji Muroya, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 3, 2013
A recurrent de novo FAM111A mutation causes Kenny-Caffey syndrome type 2Tsuyoshi Isojima, Koichiro Doi, Jun Mitsui, et al.
Journal of Inherited Metabolic Disease|April 11, 2021
Long-term outcome of urea cycle disorders: Report from a nationwide study in JapanJun Kido, Shirou Matsumoto, Johannes Häberle, et al.
Frontiers in Pediatrics|April 7, 2023
Comparison of physician- and self-assessed pubertal onset in Japanese childrenMayako Saito-Abe, Minaho Nishizato, Kiwako Yamamoto-Hanada, et al.
The Journal of Clinical Endocrinology and Metabolism|September 5, 2022
Weekly Somapacitan is Effective and Well Tolerated in Children With GH Deficiency: The Randomized Phase 3 REAL4 TrialBradley S Miller, Joanne C Blair, Michael Højby Rasmussen, et al.
Clinical Immunology (Orlando, Fla.)|December 3, 2014
Disease specificity of anti-tryptophan hydroxylase-1 and anti-AIE-75 autoantibodies in APECED and IPEX syndromeNatsuko Chida, Ichiro Kobayashi, Shunichiro Takezaki, et al.
The Journal of Clinical Endocrinology and Metabolism|March 4, 2023
Response to Letter to the Editor From Chatelain et al: "Weekly Somapacitan Is Effective and Well Tolerated in Children With GH Deficiency: The Randomized Phase 3 REAL4 Trial"Bradley S Miller, Joanne C Blair, Michael Højby Rasmussen, et al.
European Journal of Endocrinology|May 22, 2025
Efficacy, safety, and insulin-like growth factor I of weekly somapacitan in children with growth hormone deficiency: 3-year results from REAL4Bradley S Miller, Joanne C Blair, Michael Højby Rasmussen, et al.
Pageof 22

Showing results (141-150 of 212) with videos related to

Sort By:
Pageof 22
Human Genome Variation|September 7, 2025
DHX37 variants in patients with 46,XY disorders or differences of sex developmentYuko Katoh-Fukui, Daisuke Saito, Hiroko Narumi, et al.
The Journal of Clinical Endocrinology and Metabolism|July 5, 2023
Effective GH Replacement With Somapacitan in Children With GHD: REAL4 2-year Results and After Switch From Daily GHBradley S Miller, Joanne C Blair, Michael Højby Rasmussen, et al.
Journal of Human Genetics|June 5, 2015
Rare pseudoautosomal copy-number variations involving SHOX and/or its flanking regions in individuals with and without short statureMaki Fukami, Yasuhiro Naiki, Koji Muroya, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 3, 2013
A recurrent de novo FAM111A mutation causes Kenny-Caffey syndrome type 2Tsuyoshi Isojima, Koichiro Doi, Jun Mitsui, et al.
Journal of Inherited Metabolic Disease|April 11, 2021
Long-term outcome of urea cycle disorders: Report from a nationwide study in JapanJun Kido, Shirou Matsumoto, Johannes Häberle, et al.
Frontiers in Pediatrics|April 7, 2023
Comparison of physician- and self-assessed pubertal onset in Japanese childrenMayako Saito-Abe, Minaho Nishizato, Kiwako Yamamoto-Hanada, et al.
The Journal of Clinical Endocrinology and Metabolism|September 5, 2022
Weekly Somapacitan is Effective and Well Tolerated in Children With GH Deficiency: The Randomized Phase 3 REAL4 TrialBradley S Miller, Joanne C Blair, Michael Højby Rasmussen, et al.
Clinical Immunology (Orlando, Fla.)|December 3, 2014
Disease specificity of anti-tryptophan hydroxylase-1 and anti-AIE-75 autoantibodies in APECED and IPEX syndromeNatsuko Chida, Ichiro Kobayashi, Shunichiro Takezaki, et al.
The Journal of Clinical Endocrinology and Metabolism|March 4, 2023
Response to Letter to the Editor From Chatelain et al: "Weekly Somapacitan Is Effective and Well Tolerated in Children With GH Deficiency: The Randomized Phase 3 REAL4 Trial"Bradley S Miller, Joanne C Blair, Michael Højby Rasmussen, et al.
European Journal of Endocrinology|May 22, 2025
Efficacy, safety, and insulin-like growth factor I of weekly somapacitan in children with growth hormone deficiency: 3-year results from REAL4Bradley S Miller, Joanne C Blair, Michael Højby Rasmussen, et al.
Pageof 22